Recommendations of good methods examples in the biomarker literature
|
|
4
|
2140
|
November 23, 2021
|
Validity of comparing two different previously published cohort studies using IPTW for matching
|
|
5
|
2291
|
November 11, 2021
|
Interpretation of the REGEN-COV trial
|
|
22
|
10301
|
November 1, 2021
|
Probability in state Ps(t) and Hazard ratio HR in Cox model
|
|
1
|
2203
|
August 21, 2021
|
Logit Rank Plot by J.Copas in rms R package
|
|
6
|
3004
|
August 20, 2021
|
Resources for Mixed-Effect Models in Medical Contexts
|
|
7
|
3086
|
August 8, 2021
|
Question arising from JAMA Guide article "Odds Ratios—Current Best Practice and Use"
|
|
19
|
12565
|
July 13, 2021
|
Statistical Misinterpretations and Clinical Practice Guidelines: any examples?
|
|
31
|
11421
|
June 28, 2021
|
Calculating SMD from geometric mean titers
|
|
2
|
4834
|
May 26, 2021
|
The distinction between sample description (summarization) and point estimation
|
|
3
|
2113
|
May 9, 2021
|
Another null misinterpretation in a study about the association of epidural analgesia and offspring risk of autism
|
|
6
|
5376
|
May 1, 2021
|
Find skewness and kurtosis of a bivariate scatterplot
|
|
1
|
2287
|
March 29, 2021
|
Is there any intuition for the PRAUC metric?
|
|
0
|
2319
|
March 24, 2021
|
Recommended Reading: Pay No Atttention to the Model Behind the Curtain by Philip B. Stark
|
|
0
|
2579
|
March 11, 2021
|
Reporting Generalized Wilcoxon for Survival Analysis
|
|
6
|
3439
|
March 9, 2021
|
Musing on how to design "statistical functions/methods 2.0"
|
|
3
|
1940
|
March 7, 2021
|
Hazard-ratio of marginal effects?
|
|
1
|
3035
|
February 17, 2021
|
Early use of tocilizumab and steroids does not impact expansion or persistence of CAR T cells in B-ALL?
|
|
2
|
3243
|
February 17, 2021
|
Interpretation of P value
|
|
4
|
5554
|
December 31, 2020
|
Representative Covariate Settings
|
|
2
|
3729
|
December 27, 2020
|
Proper analysis and presentation of the association between a continuous exposure and a binary outcome
|
|
1
|
3035
|
November 8, 2020
|
Can treatment B be superior after the RCT if it was thought that treatment A is superior before the RCT?
|
|
5
|
3032
|
October 13, 2020
|
Time since randomization and causality
|
|
2
|
2305
|
September 27, 2020
|
Bayesian Solutions for Challenges to Frequentist Statistics
|
|
0
|
5266
|
September 22, 2020
|
Perform Cox PH when KM curves cross
|
|
1
|
3215
|
August 19, 2020
|
Thoughts on 'representativeness' and 'generalizability'
|
|
6
|
3919
|
July 19, 2020
|
Interpretation of INTERACT-2 Study in Intracerebral Hemorrhage
|
|
3
|
4664
|
June 15, 2020
|
Bayesian Qualitative Analysis of Credibility for Meta-analysis of Heterogeneous Data from RCTs
|
|
2
|
3250
|
June 12, 2020
|
What are credible priors and what are skeptical priors?
|
|
62
|
29063
|
June 9, 2020
|
Who should define reasonable priors and how?
|
|
15
|
14342
|
May 29, 2020
|